Neuphoria Therapeutics
NEUP3.3000.30% ( -0.010 )
Current ValuationThe current P/E ratio is -1.33, within the reasonable range, cheaper than 27.59% of the time in the past 1 years, and the industry ranks 239/604, the industry Median -1.93.
-1.33xP/E
$3.31Stock price
$-2.49Earnings per share
-1.33xP/E
Stock price$3.31Earnings per share$-2.49
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
020406080
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.